Late Breaking Abstracts

  • Late-breaking Abstract Submission is closed now.
  • Notification letters will be sent by the end of September 2019.

Please carefully select the topic under which you submit your abstract for review.

  1. Breast Cancer
  2. Cervical Cancer
  3. Diagnostics
  4. Endometrial Cancer
  5. Fertility/ Pregnancy
  6. Miscellaneous
  7. Ovarian Cancer
  8. Palliative Care
  9. Prevention of Gynaecologic Cancer
  10. Quality of Life after Treatment
  11. Translational Research
  12. Trophoblastic Diseases
  13. Vaginal and Vulvar Cancer
  14. Organization of Gynaecological Cancer Care

The Scientific Committee welcomes the submission of late breaking abstracts for presentation at the 21st European Congress on Gynaecological Oncology.

In order to standardise the abstract layout, we kindly ask you to read the instructions carefully, as well as the following:

  • Late-breaking abstracts should contain new information that was not yet known or fully available by the general abstract submission deadline.
  • Abstract data must not have been published, prior to the ESGO 2019 Congress.
The late-breaking abstract submission is not an extension of the abstract submission deadline.
  1. Abstracts may only be submitted Abstracts submitted by fax or email will not be accepted.
  2. Abstracts must be submitted in English. Please use UK English spelling.
  3. The presenting author of an accepted abstract must register and attend the congress.
  4. Paper poster presenters must be present and stand by their posters during their assigned poster sessions.
  5. Provide a short specific title indicating the nature of the investigation. The background and goals of the study should appear clearly to the reader. The methods and results must contain data, and the conclusion should be clearly expressed.

Following structure will be required:

  • Introduction/Background*
  • Methodology
  • Results*
  • Conclusion*
  • Disclosures*

* mandatory fields

  1. The title may not exceed 50 words. The abstract text may not be longer than 300 words (excluding title and disclosures)
  2. All abbreviations must be defined the first time they appear in your text (but, do not define in the title).
  3. Tables (maximum 2), charts and other graphics (maximum 2) are permitted and must be in JPG format, high resolution.
  4. Disclosure of potential conflict of interest (e.g. grant support, consultancy, membership on advisory councils, speaker’s bureau) by all authors and source of funding are mandatory. Each listed author should prepare a one sentence statement that will be published with the abstract. All disclosures should be listed within the last 3 year.
  5. Abstracts from commercial entities will be considered. However, abstracts reporting results from collaborative research conducted by independent (non-company) investigators and investigators who are employees of commercial entities will not be accepted unless the independent (academic, clinician and/or scientist) investigators are included as authors.
  6. Please make sure to state your correct e-mail After having submitted your abstract, you will receive a confirmation by e-mail with the following information:
  • reference number of your abstract (for correspondence and questions that might arise)
  • your personal user code and password.

If you do not receive a confirmation by e-mail please contact

  1. Should you wish to make corrections to an abstract already submitted or if you wish to submit other abstracts later, you may use your personal access code. This will shorten the submission procedure.

Corrections to abstracts can only be made up to the deadline of 10 September 2019, 23:59h CET.

  1. We kindly ask you to upload a picture of the presenting author. Please prepare the photo in one of the following formats: JPG or GIF with a max. size of 1 MB. By uploading the picture you agree that the photo will be used in the Scientific Programme, Mobile App.



Each abstract will be reviewed by several experts and final selection will be made by the Scientific Programme Committee. Notification of acceptance or rejection of submitted abstracts will be sent to the corresponding authors via email in October 2019. Full instructions concerning preparation and presentation will be included.



Late breaking abstracts will be published in the online supplement of the International Journal of Gynaecological Cancer as well as on the ESCO Congress’s website and in the Mobile App.

Late abstracts will be published on the first day of the congress (2 November 2019).

The presenting author of an accepted Late abstract must register and attend at the Congress.



If you have questions regarding abstracts or need assistance, please contact the abstract team at For technical questions please contact

When contacting the abstract team please refer to the name of the congress.

Abstract hotline: +41 61 686 77 22 (Monday - Friday during CET business hours)

You may also like


Reasons to Attend


ESGO 2019

100+ Webcasts on ESGO eAcademy


Explore it Now!

Porch of the Caryatids

Photo Gallery

Great moments from ESGO 2019!


View it Now!